If you missed Tarson Products’ IPO allotment, here’s what you should know

If you missed Tarson Products’ IPO allotment, here’s what you should know
  • Tarsons Products announced its share allotment status on Tuesday.
  • The grey market premium of the Indian labware company Tarsons Products is ₹160.
  • The IPO of the company was subscribed 77.49 times on the last day of bidding.
The allotment status of Indian labware company Tarsons Products was announced on Tuesday and by now the investors, who unfortunately did not get the shares, should start getting their refunds.

If you have not checked whether you received the initial public offering (IPO) allotment or not, click here and follow the procedure.

All the investors who got the allotment will receive the shares in their demat account on the date of listing, which in this case is November 26.

Usually every applicant gets a message on their registered phone number, highlighting whether the funds are blocked or unblocked.

Blocked funds indicate that the shares have been transferred to the investor, whereas the unblocked fund means that the cash has been transferred back to the investor’s bank account.


Investors receive a validity period while making the payments for the shares. The IPO amount is usually refunded one day later the IPO allotment or before the end of the validity period.

If you missed Tarson Products’ IPO allotment, here’s what you should know
BI India

Tarsons Products opened its IPO on November 15 to November 17, at a price band of ₹635-₹662 per share. The IPO received subscriptions for 77.49 times the number of shares offered in the three days of IPO bidding process.

The grey market premium of the company’s shares show a premium of ₹160 on November 23.

The company has raised over ₹1,024 crore through the IPO of a fresh issue of equity shares worth ₹150 crore and an offer for sale (OFS) of 1.32 crore equity shares that will be sold by promoters and an investor.

Tarsons Products is engaged in designing, developing, manufacturing and supplying a diverse range of quality labware products used in laboratories across research organisations, academic institutes, pharmaceutical firms, diagnostics companies and hospitals.

Jio is slowing down in the race to 500 million subscribers – a goal set by none other than Mukesh Ambani

NoBroker is the 38th Indian startup to be valued over a billion dollars this year

Vodafone Idea hikes tariffs by up to ₹500 for its popular plans